{
    "paper_id": "PMC7218761",
    "metadata": {
        "title": "World Heart Federation Briefing on Prevention: Coronavirus Disease 2019 (COVID-19) in Low-Income Countries",
        "authors": [
            {
                "first": "Friedrich",
                "middle": [],
                "last": "Thienemann",
                "suffix": "",
                "email": "friedrich.thienemann@uct.ac.za",
                "affiliation": {}
            },
            {
                "first": "Fausto",
                "middle": [],
                "last": "Pinto",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Diederick",
                "middle": [
                    "E."
                ],
                "last": "Grobbee",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Michael",
                "middle": [],
                "last": "Boehm",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Nooshin",
                "middle": [],
                "last": "Bazargani",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Junbo",
                "middle": [],
                "last": "Ge",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Karen",
                "middle": [],
                "last": "Sliwa",
                "suffix": "",
                "email": "karen.sliwa-hahnle@uct.ac.za",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Coronaviruses belong to a family of viruses that can cause mild disease such as a common cold, but also severe respiratory disease such as Middle East Respiratory Syndrome (MERS-CoV) or Severe Acute Respiratory Syndrome (SARS-CoV). The novel coronavirus epidemic Coronavirus Disease 2019 (COVID-19) is caused by a coronavirus named SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).",
            "cite_spans": [],
            "section": "1. The novel coronavirus ::: Important facts",
            "ref_spans": []
        },
        {
            "text": "SARS-CoV-2 is thought to have a zoonotic origin and was first isolated from patients with pneumonia in Wuhan, China. The spread from human-to-human is mainly an aerosol transmission through contaminated respiratory droplets (coughing and sneezing). In addition, respiratory droplets containing the virus may contaminate surfaces up to 96 hours, for example screens of smart phones (Figure 2).",
            "cite_spans": [],
            "section": "2. Transmission and infection ::: Important facts",
            "ref_spans": [
                {
                    "start": 389,
                    "end": 390,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Signs and symptoms of COVID-19 include flu-like symptoms such as fever, cough, fatigue, headache, sore throat, shortness of breath and myalgia. In rare cases nausea, vomiting and diarrhoea have occurred. In severe cases pneumonia, acute respiratory distress syndrome (ARDS), multi-organ failure and death have been reported (Figure 3).",
            "cite_spans": [],
            "section": "3. Signs and symptoms ::: Important facts",
            "ref_spans": [
                {
                    "start": 332,
                    "end": 333,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "Basic recommendations to prevent COVID-19: Follow six easy rules to reduce the risk of coronavirus transmission. The rules are built on the principle of protecting yourself and protecting others (Figure 4).",
            "cite_spans": [],
            "section": "4. Prevention ::: Important facts",
            "ref_spans": [
                {
                    "start": 203,
                    "end": 204,
                    "mention": "4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "People with chronic underlying disease may be at increased risk of severe COVID-19 disease and death (Table 1). In the largest Chinese cohort, 16% of patients developed severe disease with a mortality rate of 8.1% [2]. Of those patients with severe disease, 38.7% had co-morbidities. Therefore, patients with co-morbidities require more rigorous prevention mechanisms. For people with chronic respiratory disease (e.g. chronic obstructive airways disease), infectious diseases (e.g. HIV and tuberculosis), chronic cardiovascular disease (e.g. cardiomyopathy, previous myocardial infarction, rheumatic heart disease), cancer or autoimmune diseases we recommend:",
            "cite_spans": [
                {
                    "start": 215,
                    "end": 216,
                    "mention": "2",
                    "ref_id": "BIBREF1"
                }
            ],
            "section": "Recommendations on prevention for special populations",
            "ref_spans": [
                {
                    "start": 108,
                    "end": 109,
                    "mention": "1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "In case SARS-CoV-2/COVID-19 begins to spread in low-income countries at high risk of airborne diseases, as described above, containment may not be realistic and response efforts will likely need to transition to various mitigation strategies, which could include isolating ill people at home, closing schools, universities, places of religious worship and public events, which would also include attending funerals. Please follow recommendations of leading health organizations as outlined in Table 2.",
            "cite_spans": [],
            "section": "Recommendations on prevention for special populations",
            "ref_spans": [
                {
                    "start": 499,
                    "end": 500,
                    "mention": "2",
                    "ref_id": "TABREF1"
                }
            ]
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Risk factors for severe disease.\n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Important resources and information.\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Figure 1: Global map of SARS-CoV-2/COVID-19 epidemic by region.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: Transmission and infection.",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: Signs and symptoms.",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Figure 4: Prevention.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "An interactive web-based dashboard to track COVID-19 in real time",
            "authors": [],
            "year": 2020,
            "venue": "Lancet Infect Dis",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S1473-3099(20)30120-1"
                ]
            }
        },
        "BIBREF1": {
            "title": "Clinical Characteristics of Coronavirus Disease 2019 in China",
            "authors": [],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "Looming threat of COVID-19 infection in Africa: Act collectively, and fast",
            "authors": [],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0140-6736(20)30464-5"
                ]
            }
        },
        "BIBREF3": {
            "title": "A Novel Coronavirus from Patients with Pneumonia in China, 2019",
            "authors": [],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "8",
            "pages": "727-33",
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2001017"
                ]
            }
        },
        "BIBREF4": {
            "title": "Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS",
            "authors": [],
            "year": 2006,
            "venue": "Diabet Med",
            "volume": "23",
            "issn": "6",
            "pages": "623-8",
            "other_ids": {
                "DOI": [
                    "10.1111/j.1464-5491.2006.01861.x"
                ]
            }
        },
        "BIBREF5": {
            "title": "Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): A systematic review and meta-analysis",
            "authors": [],
            "year": 2016,
            "venue": "Int J Infect Dis",
            "volume": "49",
            "issn": "",
            "pages": "129-33",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ijid.2016.06.015"
                ]
            }
        }
    }
}